A major problem in cancer treatment is resistance to chemotherapy. An international team led by biochemists Robert Ahrends of the University of Vienna and Jan Medenbach of the University of Regensburg has now identified chemoresistance as the result of a specific cellular stress response, which is triggered in cancer cells by ‘misfolded proteins’ and leads to changes in cellular metabolism. The researchers are now presenting this new mechanism in *Nature Communications*.
To gain a precise molecular biological understanding of the Unfolded Protein Response (UPR), the researchers applied state-of-the-art analytical methods as part of a multi-omics approach – that is, the combination of large datasets from genetics, protein and metabolic research. In the process, they identified molecules that had not previously been linked to the cellular stress response.
The regulation of these genes led, for example, to an altered folate-dependent one-carbon metabolism and, furthermore, to complete resistance of the cells to chemotherapeutic agents that target this metabolic pathway. This new finding could lead to improved strategies for overcoming resistance in cancer therapy.
Reference:
Press release:
https://news.univie.ac.at/presse/aktuelle-pressemeldungen/detailansicht/artikel/wie-krebszellen-unter-stress-chemo-resistenzen- entwickeln/